ClinicalTrials.gg
Sign In

Antiphospholipid Syndrome clinical trials

The registry lists 121 studies for Antiphospholipid Syndrome across more than 10 countries. 52 are recruiting or about to start. 83 of them are mainly about Antiphospholipid Syndrome (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-28.

Get an email when these change. Save the Antiphospholipid Syndrome studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
41
Recruiting
38
Status unknown
13
Not yet recruiting
11
Terminated
7
Withdrawn
6

Phase

Phase 2
20
Phase 1
14
Phase 4
10
Phase 3
6
Early Phase 1
3

Where

France
31
China
25
United States
19
Egypt
10
Canada
7
Italy
5

Who runs them

Central Hospital, Nancy, France (7) · Centre Hospitalier Universitaire de Nīmes (6) · China Immunotech (Beijing) Biotechnology Co., Ltd. (6) · Assistance Publique - Hôpitaux de Paris (6) · Hospital for Special Surgery, New York (5) · Peking University People's Hospital (3) · Institute of Hematology & Blood Diseases Hospital, China (3) · New Valley University (3)

What is being tested here

Drugs under test in Antiphospholipid Syndrome studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
YTS109606
Enoxaparin103
Belimumab112
BRL-301101
Anti-CD19 CAR T Cells Preparation101
Daratumumab101
Anifrolumab101
Evarucabgene Autoleucel101
Zanubrutinib101
Warfarin101

Drug classes tested here Factor Xa inhibitors 5

Coming up

1phase 3 study under way
19studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 38 Antiphospholipid Syndrome studies recruiting now, 14 (37%) set no upper age limit and 19 (50%) stop at 75 or younger. 5 (13%) take children under 18. 2 (5%) are for women only and 0 (0%) for men only; 5 (13%) take healthy volunteers.

Recruiting studies that take each age, of 38
AgeWomenMen
104 (11%)4 (11%)
1836 (95%)35 (92%)
3036 (95%)34 (89%)
4035 (92%)34 (89%)
5034 (89%)34 (89%)
6534 (89%)34 (89%)
7520 (53%)20 (53%)
8516 (42%)16 (42%)

Across all 121 studies, recruiting or not: 44% stop at 75 or younger and 31% at 65; 12% take children; 20% are for women only and 0% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 121. Browse all 121 → or search them.